Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money
Tickers AVIR GILD MRK RHHBY
Tags Market News GILD MRK
From Motley Fool
$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years
Tickers ABBV ARKG GILD ILMN
Tags PFE ARKG PACB
From Motley Fool
Investors Should Avoid High-Risk Atossa Therapeutics
Tickers AGNPF ATOS GILD LLY
Tags AGNPF GILD Market News
From InvestorPlace
Why Investors Should Like BioNTech's Latest Deal With Gilead
Tickers ALPMY BNTX GILD PFE
Tags ALPMY Market News BNTX
From Motley Fool
Gilead Sciences (GILD) Q2 2021 Earnings Call Transcript
Tickers GILD
Tags GILD Market News
From Motley Fool
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Tickers ABBV ABSI ACET ALKS
Tags FDA IBB ORTX
From Benzinga
Gilead Sciences Exceeds Expectations As Remdesivir Success Cushions Slump In HIV Franchise
Tickers GILD
Tags News Guidance Trading Ideas
From Benzinga
This 1 Thing in Pfizer's Earnings Report May be a Coronavirus Game Changer
Tickers BNTX GILD PFE
Tags PFE BNTX GILD
From Motley Fool
Recap: Gilead Sciences Q2 Earnings
Tickers GILD
Tags BZI/Recaps Market News Benzinga
From Benzinga
Sales of Gilead’s COVID-19 drug top $800 million
Tickers GILD
Tags GILD
From MarketWatch
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
Tickers GILD INCY LLY
Tags Biotech Health Care LLY
From Benzinga
This Biotech Stock Is Too Cheap to Ignore
Tickers ABBV ALXO GILD IMAB
Tags ABBV TRIL PFE
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Tickers ABBV ABOS ACET AGIO
Tags MMSI FUSN RHHBY
From Benzinga
Think Carefully Before Speculating on Atossa Therapeutics
Tickers ATOS GILD
Tags GILD ATOS Market News
From InvestorPlace
A Look Into Gilead Sciences Price Over Earnings
Tickers GILD
Tags News Intraday Update Benzinga
From Benzinga
Gilead Ordered To Pay Attorney Fees In Shareholder Lawsuit
Tickers GILD
Tags Biotech Benzinga Health Care
From Benzinga
Understanding Gilead Sciences's Unusual Options Activity
Tickers GILD
Tags Market News Markets GILD
From Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Tickers ABBV ACIU AGIO AGRX
Tags ITRM CDNA NVCR
From Benzinga
Why This Company’s Covid-19 Vaccine Is Just the Beginning
Tickers BNTX GILD PFE
Tags NASDAQ:BNTX,NYSE:PFE,NASDAQ:GILD Market News GILD
From InvestorPlace
3 Biotechs That Could Make Big Acquisitions This Year
Tickers ABBV GILD LLY VRTX
Tags XBI Market News ABBV
From Motley Fool
The FDA may not fully approve a COVID-19 vaccine until January. Here’s why
Tickers BNTX GILD JNJ MRNA
Tags GILD BNTX JNJ
From MarketWatch
Understanding Gilead Sciences's Unusual Options Activity
Tickers GILD
Tags Market News GILD Markets
From Benzinga
Four-Year Biktarvy Data Show High Efficacy, Durable Viral Suppression In Untreated HIV Patients
Tickers GILD
Tags News Briefs Benzinga
From Benzinga
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
Tickers GILD
Tags Briefs News Phase 3 Trial
From Benzinga
2 Top Pharma Stocks to Buy Right Now
Tickers GILD JNJ MRK
Tags JNJ GILD Market News
From Motley Fool
Analyzing Gilead Sciences's Unusual Options Activity
Tickers GILD
Tags Benzinga Options BZI/UOA
From Benzinga
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
Tickers BNTX GILD GSK MRNA
Tags General Covid/19 PFE
From Benzinga
Investing $72,036 Into These 3 Stocks Can Generate $300 in Monthly Income for Your Portfolio
Tickers GILD MO VZ
Tags MO Market News VZ
From Motley Fool
5 Stocks to Own for the Surge in Coronavirus Variants
Tickers ABT AMZN BNTX CVS
Tags ABT REGN PFE
From Motley Fool
Gilead's Remdesivir Fails To Show Antiviral Effects Against COVID-19 In Small WHO Study
Tickers GILD
Tags General GILD Market News
From Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.